Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2

Status

Completed 25Terminated 4Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1CNS 1

Conditions

Pancreatic Neoplasms 1Neurofibromatosis 2 1Macular Degeneration 1Lung Neoplasms 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × aflibercept × Clear all
NCT03710564 2023-01-30

MERLIN

Novartis

Phase 3 Terminated
535 enrolled 14 charts
CNS

Macular Degeneration, Neurofibromatosis 2

NCT00794417 2020-12-10

A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

Regeneron Pharmaceuticals

Phase 1/2 Terminated
60 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00574275 2016-06-07

VANILLA

Sanofi

Phase 3 Terminated
546 enrolled 14 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01955629 2016-04-18

AMOR

Sanofi

Phase 1/2 Terminated
4 enrolled 7 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡